1. Home
  2. SCPH vs NAK Comparison

SCPH vs NAK Comparison

Compare SCPH & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • NAK
  • Stock Information
  • Founded
  • SCPH 2013
  • NAK 1983
  • Country
  • SCPH United States
  • NAK Canada
  • Employees
  • SCPH N/A
  • NAK N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • NAK Precious Metals
  • Sector
  • SCPH Health Care
  • NAK Basic Materials
  • Exchange
  • SCPH Nasdaq
  • NAK Nasdaq
  • Market Cap
  • SCPH 274.7M
  • NAK 243.1M
  • IPO Year
  • SCPH 2017
  • NAK 2002
  • Fundamental
  • Price
  • SCPH $3.35
  • NAK $0.46
  • Analyst Decision
  • SCPH Strong Buy
  • NAK Strong Buy
  • Analyst Count
  • SCPH 2
  • NAK 1
  • Target Price
  • SCPH $15.00
  • NAK $1.30
  • AVG Volume (30 Days)
  • SCPH 503.0K
  • NAK 3.4M
  • Earning Date
  • SCPH 11-13-2024
  • NAK 11-15-2024
  • Dividend Yield
  • SCPH N/A
  • NAK N/A
  • EPS Growth
  • SCPH N/A
  • NAK N/A
  • EPS
  • SCPH N/A
  • NAK N/A
  • Revenue
  • SCPH $30,278,000.00
  • NAK N/A
  • Revenue This Year
  • SCPH $195.62
  • NAK N/A
  • Revenue Next Year
  • SCPH $145.07
  • NAK N/A
  • P/E Ratio
  • SCPH N/A
  • NAK N/A
  • Revenue Growth
  • SCPH 303.87
  • NAK N/A
  • 52 Week Low
  • SCPH $3.08
  • NAK $0.23
  • 52 Week High
  • SCPH $6.71
  • NAK $0.56
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 33.76
  • NAK 55.19
  • Support Level
  • SCPH $3.25
  • NAK $0.31
  • Resistance Level
  • SCPH $3.60
  • NAK $0.49
  • Average True Range (ATR)
  • SCPH 0.24
  • NAK 0.04
  • MACD
  • SCPH -0.05
  • NAK -0.00
  • Stochastic Oscillator
  • SCPH 19.30
  • NAK 35.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About NAK Northern Dynasty Minerals Ltd.

Northern Dynasty Minerals Ltd is a Canadian mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a significant deposit of copper, gold, molybdenum, and silver into a modern mining operation.

Share on Social Networks: